Medline Inc. Class A Common Stock

United States

United Kingdom

European Union

Japan

China

MDLN▼

S&P 500 Futures Edge Higher as Inflation Worries Ease

US stock futures are pointing higher, with E mini S&P 500 contracts up about 0.2% and Dow futures also in positive territory, as softer inflation expectations ease borrowing cost fears. UK gilt yields slipped below 4.9% and US 10-year Treasury yields hover near 4.6%, signaling that rates may not rise as sharply as feared. Purchasing manager indexes across Europe and Japan show services and manufacturing activity just above the growth line. Among top movers, Shopify jumped 16.98% after a strong Q2 report and analyst upgrades, Bending Spoons surged 16.82% on European expansion plans, and Agnico Eagle Mines gained 9.85% on fresh analyst attention. On the downside, Space Exploration Technologies fell 13.61% after posting a quarterly loss, Medline declined 12.79% on weaker year-over-year earnings, and Astera Labs dropped 11.96% following mixed analyst updates. Today's earnings slate includes Cloudflare, Atlassian, Twilio, Roku, Warner Bros. Discovery, Airbnb, Monster Beverage, and Ralph Lauren, while China inflation data due Sunday and Berkshire Hathaway's Q2 results on Saturday are also on the radar.

BSP ▲SHOP ▲AEM ▲ALAB ▼MDLN ▼SPCX ▼

BSP · Demand · Positive European expansion plans drive growth

Bending Spoons · Demand · Positive European expansion plans drive growth

SHOP · Capital · Positive Strong Q2 report and analyst upgrades boost shares.

AEM · Capital · Positive Fresh analyst attention drives gains.

ALAB · Capital · Negative Mixed analyst updates weigh on shares.

MDLN · Capital · Negative Weaker year-over-year earnings hurt stock.

Read original ↗

Simply Wall St·60dRead more →

United States

MDLN

Medline raises sales outlook but cuts EBITDA guidance after fire and tariff refunds

Medline raised its full-year organic sales growth outlook to 9% to 10% while lowering adjusted EBITDA guidance to $3.3 billion to $3.4 billion, citing operational investments, quality remediation, retail weakness, and costs from a June fire at its Tracy, California distribution center. Second-quarter net sales rose 12% to $7.7 billion, led by a 16% increase in Supply Chain Solutions and a 15% increase in U.S. acute-care sales. Adjusted EBITDA increased 13% to $1.1 billion, including a $243 million net benefit from IEEPA tariff refunds, but underlying profitability was pressured by higher costs. The Tracy fire reduced first-half net income by $336 million, and the company expects an additional $50 million to $100 million in related costs during the second half. Medline is expanding its California distribution network and expects its footprint to reach nearly 5 million square feet by mid-2027.

MDLN

MDLN · Capital · Neutral Raises sales outlook but cuts EBITDA guidance due to fire costs and retail weakness.

Read original ↗

MarketBeat·60dRead more →

MDLN▲

Medline leases two new Northern California distribution centers totaling over 1.6 million square feet

Medline announced a lease agreement for two new distribution centers in Northern California, totaling over 1.6 million square feet of space. This move replaces a 1-million-square-foot facility destroyed by fire on June 11 and represents a 45% expansion of the company's customer-facing footprint in the region compared to one month ago. The new capacity includes a 925,000-square-foot warehouse in Tracy available for immediate occupancy and a 709,000-square-foot facility in Stockton scheduled to open in January 2027. The Tracy site is being prepared to integrate AI-powered logistics technologies and will soon support deliveries through Medline's dedicated truck fleet. The company expects its total distribution footprint in California to reach nearly 5 million square feet by mid-2027, supported by an additional 1-million-square-foot facility under construction in Perris.

MDLN ▲

MDLN · Supply · Positive Medline leases two new distribution centers totaling over 1.6M sq ft, replacing a fire-destroyed facility and expanding footprint 45%.

Read original ↗

Insider Monkey·85dRead more →

MDLN▼

Pomerantz Law Firm Investigates Medline Industries Over Potential Securities Fraud

Pomerantz LLP is investigating claims on behalf of investors of Medline Industries, Inc. regarding potential securities fraud or unlawful business practices. The investigation follows a June 2, 2026 FDA warning letter citing significant violations of Current Good Manufacturing Practice regulations, including failure to thoroughly investigate batch discrepancies. On that news, Medline’s stock fell $2.56 per share, or 7.16%, to close at $33.19 per share.

MDLN ▼

MDLN · Regulation · Negative FDA warning letter citing significant violations of Current Good Manufacturing Practice regulations, leading to stock price decline.

Read original ↗

GlobeNewswire·89dRead more →

MDLN▼

ICU Medical Outshines Medline as a Value Stock

ICU Medical is seen as a better value stock than Medline based on Zacks Investment Research analysis. ICU Medical holds a Zacks Rank of #2 (Buy) and a Value grade of B, while Medline has a Zacks Rank of #3 (Hold) and a Value grade of C. ICU Medical's forward P/E ratio stands at 16.90 compared to Medline's 24.08, and its PEG ratio is 1.54 versus Medline's 5.19. Additionally, ICU Medical's price-to-book ratio is 1.63, lower than Medline's 2.47. The improving earnings outlook and stronger valuation metrics make ICU Medical the preferred choice for value investors.

ICUI ▲MDLN ▼

ICUI · Capital · Positive Zacks analysis highlights ICU Medical's superior valuation metrics (lower P/E, PEG, P/B) and a Buy rating, making it a preferred value stock.

MDLN · Capital · Negative Zacks analysis shows Medline has weaker valuation metrics (higher P/E, PEG, P/B) and a Hold rating, making it less attractive as a value stock.

Read original ↗

Zacks Investment Research·108dRead more →